DelveInsight’s, “Mesothelioma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 50+ ...

The antibody has shown promising results in preclinical studies, demonstrating 'superior' anti-tumour activity.

Basophils trigger a cytokine cascade that improves antitumor immunity in mice, offering potential targets for cancer ...

Immunostimulant therapy using agonistic cytokines or activating antibodies has been associated with off-target side effects, failure to preferentially activate cytotoxic lymphocytes (CTLs) over ...

Discover how hyperbaric oxygen therapy influences telomeres, stem cells, and mitochondria. New research reveals promising ...

Researchers found that e-cigarette exposure during pregnancy can disrupt fetal lung development, increase oxidative stress, ...

Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata” or the "Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today presented data at the American Association for Cancer Research (AACR) IO Annual Meeting ...

iNKTs function as "master regulators,” combining the cytotoxic capabilities of NK cells with T-cell-like antigen recognition ...

Mutations in serine-threonine kinase 11 (STK11) and liver kinase B1 (LKB1) are associated with disease progression in ...

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States Department of Chemistry and Biochemistry, University of North ...